is a proven life science leader with deep expertise in turning breakthrough MedTech and Biotech innovations into market-shaping companies. He partners with founders and universities to develop, launch, and scale ventures built on transformative IP. He brings nearly 15 years of leadership at Johnson & Johnson—spanning external innovation, R&D, portfolio strategy, and digital surgery—along with global development experience at Synthes (acquired by J&J) and co-ownership of a robotics company. Christopher holds engineering and MBA degrees from Drexel and Villanova, graduating both top of class. An inventor on multiple patents across robotics, implants, cold-plasma, and AI imaging analytics, he combines technical depth, business acumen, and entrepreneurial grit to drive startup success